Lamin B1 regulates the growth of hepatocellular carcinoma cells by influencing telomerase activity.
- Author:
Ruiguan WANG
1
;
Si CHEN
2
;
Zhijia SUN
3
;
Shikun WANG
4
;
Jie WANG
5
;
Lingmei QIN
6
;
Jiangbo LI
6
Author Information
- Publication Type:Journal Article
- Keywords: cell senescence; hepatocellular carcinoma; nuclear lamina protein B1 (LMNB1); telomerase; telomere
- MeSH: Animals; Mice; Telomerase/metabolism*; Carcinoma, Hepatocellular/genetics*; Liver Neoplasms/genetics*; Telomere Shortening; In Situ Hybridization, Fluorescence; Mice, Nude; Telomere/pathology*; Carcinogenesis
- From: Chinese Journal of Biotechnology 2023;39(4):1609-1620
- CountryChina
- Language:Chinese
- Abstract: Lamin B1 (LMNB1) is highly expressed in liver cancer tissues, and its influence and mechanism on the proliferation of hepatocellular carcinoma cells were explored by knocking down the expression of the protein. In liver cancer cells, siRNAs were used to knock down LMNB1. Knockdown effects were detected by Western blotting. Changes in telomerase activity were detected by telomeric repeat amplification protocol assay (TRAP) experiments. Telomere length changes were detected by quantitative real-time polymerase chain reaction (qPCR). CCK8, cloning formation, transwell and wound healing were performed to detect changes in its growth, invasion and migration capabilities. The lentiviral system was used to construct HepG2 cells that steadily knocked down LMNB1. Then the changes of telomere length and telomerase activity were detected, and the cell aging status was detected by SA-β-gal senescence staining. The effects of tumorigenesis were detected by nude mouse subcutaneous tumorigenesis experiments, subsequent histification staining of tumors, SA-β-gal senescence staining, fluorescence in situ hybridization (FISH) for telomere analysis and other experiments. Finally, the method of biogenesis analysis was used to find the expression of LMNB1 in clinical liver cancer tissues, and its relationship with clinical stages and patient survival. Knockdown of LMNB1 in HepG2 and Hep3B cells significantly reduced telomerase activity, cell proliferation, migration and invasion abilities. Experiments in cells and tumor formation in nude mice had demonstrated that stable knockdown of LMNB1 reduced telomerase activity, shortened telomere length, senesced cells, reduced cell tumorigenicity and KI-67 expression. Bioinformatics analysis showed that LMNB1 was highly expressed in liver cancer tissues and correlated with tumor stage and patient survival. In conclusion, LMNB1 is overexpressed in liver cancer cells, and it is expected to become an indicator for evaluating the clinical prognosis of liver cancer patients and a target for precise treatment.
